A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell death
- 1 May 2001
- journal article
- research article
- Published by Elsevier BV in Current Biology
- Vol. 11 (9), 691-696
- https://doi.org/10.1016/s0960-9822(01)00199-3
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Chemokine Signaling and Functional Responses: The Role of Receptor Dimerization and TK Pathway ActivationAnnual Review of Immunology, 2001
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- Cells on the Move: A Dialogue Between Polarization and MotilityIUBMB Life, 2000
- Distinct CXC Chemokines Mediate Tumorigenicity of Prostate Cancer CellsThe American Journal of Pathology, 1999
- THE CENTRAL EFFECTORS OF CELL DEATH IN THE IMMUNE SYSTEMAnnual Review of Immunology, 1999
- The host—tumor immune conflict: from immunosuppression to resistance and destructionImmunology Today, 1997
- Costimulation, tolerance and ignorance of cytolytic T lymphocytes in immune responses to tumor antigensLife Sciences, 1997
- Cytokines, tumour-cell death and immunogenicity: a question of choiceImmunology Today, 1997
- Are Growth Factors Chemotactic Agents?Experimental Cell Research, 1995
- A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human MelanomaScience, 1995